The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

Mytesi Seeks FDA Orphan Drug Designation in Breast Most cancers Diarrhea

Napo Prescription drugs has submitted an orphan drug designation utility to the U.S. Meals and Drug Administration (FDA) for novel prescription drug...

Mixture Therapies Might Enhance Survival in EGFR+ Lung Most cancers

Treating sufferers with mixture remedy approaches might enhance survival for sufferers with EGFR-positive lung most cancers compared with monotherapy treamtents, similar to...

Photobiomodulation System Cuts Oral Mucositis in Head and Neck Most cancers

An LED-based intraoral machine for photobiomodulation remedy appeared protected and decreased extreme oral mucositis versus a placebo process for sufferers with head...

The Significance of Consciousness and Self-Advocacy in A number of Myeloma

Tamara Mobley was solely 33 years outdated when a nagging again ache led to a a number of myeloma prognosis. As a...

Why Multidisciplinary Care is Essential in Prostate Most cancers

When being handled for prostate most cancers, sufferers can place themselves to obtain the perfect care potential by seeing a multidisciplinary crew...

Hot Topics